Effect of NFκB Inhibition by CAPE on Skeletal Muscle Ischemia-Reperfusion Injury

Journal of Surgical Research

Volumn 153, Issue 2, 2009, Pages 254-262

  Andrade Silva, Alessandra R ^a   Ramalho, Fernando S ^a   Ramalho, Leandra N Z ^a   Saavedra Lopes, Milena ^a   Jordão Jr , Alceu A ^a   Vanucchi, Hélio ^a   Piccinato, Carlos E ^a   Zucoloto, Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CAPE; ischemia reperfusion; NF B; propolis; skeletal muscle

Indexed keywords

4 HYDROXYNONENAL; AMINOTRANSFERASE; CAFFEIC ACID PHENETHYL ESTER; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; CAFFEIC ACID DERIVATIVE; DRUG DERIVATIVE; PHENETHYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MUSCLE INJURY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; ANIMAL; DRUG ANTAGONISM; INJURY; TRADITIONAL MEDICINE; WISTAR RAT;

ANIMALS; CAFFEIC ACIDS; MALE; MEDICINE, TRADITIONAL; MUSCLE, SKELETAL; NF-KAPPA B; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 64849102407     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.04.009     Document Type: Article

References (46)

1. Kerrigan C.L., and Stotland M.A. Ischemia reperfusion injury: A review. Microsurgery 14 (1993) 165
2. Schlag M.G., Harris K.A., and Potter R.F. Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle. Am J Physiol Heart Circ Physiol 280 (2001) H1716
3. Blaisdell F.W. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: A review. Cardiovasc Surg 10 (2002) 620
4. Woodruff T.M., Arumugam T.V., and Shiels I.A. Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J Surg Res 116 (2004) 81
5. Gute D.C., Ishida T., Yarimizu K., et al. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179 (1998) 169
6. Grisotto P.C., Santos A.C., Coutinho-Neto J., et al. Indicators of oxidative injury and alterations of the cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion. J Surg Res 92 (2000) 1
7. Gilmore T.D. Introduction to NF-κB: Players, pathways, perspectives. Oncogene 25 (2006) 6680
8. Lille S.T., Lefler S.R., Mowlavi A., et al. Inhibition of the initial wave of NF-κB activity in rat muscle reduces ischemia/reperfusion injury. Muscle Nerve 24 (2001) 534
9. Sasaki H., Zhu L., Fukuda S., et al. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo hypoxia/reoxygenation-mediated myocardial angiogenesis. Int J Tissue React 22 (2000) 93
10. Zou L., Attuwaybi B., and Kone B.C. Effects of NF-κB inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 284 (2003) G713
11. Howard E.F., Chen Q., Cheng C., et al. NF-κB is activated and ICAM-1 gene expression is up-regulated during reoxygenation of human brain endothelial cells. Neurosci Lett 248 (1998) 199
12. Yoshidome H., Kato A., Edwards M.J., et al. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB. Hepatology 30 (1999) 203
13. Donnahoo K.K., Meldrum D.R., Shenkar R., et al. Early renal ischemia, with or without reperfusion, activates NFκB and increases TNF-α bioactivity in the kidney. J Urol 163 (2000) 1328
14. Ross S.D., Kron I.L., Gangemi J.J., et al. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol 279 (2000) L528
15. Qi W.-N., Chaiyakit P., Cai Y., et al. NF-κB p65 involves in reperfusion injury and iNOS gene regulation in skeletal muscle. Microsurgery 24 (2004) 316
16. Park J.W., Qi W.N., Cai Y., et al. Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-κB activation. Plast Reconstr Surg 120 (2007) 1808
17. Fidan H., Sahin O., Yavuz Y., et al. Caffeic acid phenethyl ester reduces mortality and sepsis-induced lung injury in rats. Crit Care Med 35 (2007) 2822
18. Fesen M.R., Pommier Y., Leteurtre F., et al. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol 48 (1994) 595
19. Chung T.W., Moon S.K., Chang Y.C., et al. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J 18 (2004) 1670
20. Ozyurt B., Iraz M., Koca K., et al. Protective effects of caffeic acid phenethyl ester on skeletal muscle ischemia-reperfusion injury in rats. Mol Cell Biochem 292 (2006) 197
21. Ozyurt H., Ozyurt B., Koca K., et al. Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia-reperfusion-induced oxidative stress. Vascul Pharmacol 47 (2007) 108
22. Koltuksuz B.U., Özen S., Uz E., et al. Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats. J Pediatr Surg 34 (1999) 1458
23. Irmak M.K., Koltuksuz U., Kutlu N.O., et al. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with α-tocopherol in rat kidneys. Urol Res 29 (2001) 190
24. Uz E., Sogut S., Sahin S., et al. The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion. World J Urol 20 (2002) 264
25. Khan M., Elango C., Ansari M.A., et al. Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem 102 (2007) 365
26. Natarajan K., Singh S., Burke T.R., et al. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci USA 93 (1996) 9090
27. Strock P.E., and Majno G. Vascular responses to experimental tourniquet ischemia. Surg Gynecol Obstet 129 (1969) 309
28. Herbert K.J., Hickey M.J., Lepore D.A., et al. Effects of the endothelin receptor antagonist Bosentan on ischemia/reperfusion injury in rat skeletal muscle. Eur J Pharmacol 424 (2001) 59
29. Erkanli K., Kayalar N., Erkanli G., et al. Melatonin protects against ischemia/reperfusion injury in skeletal muscle. J Pineal Res 39 (2005) 238
30. Suetsugu H., Iimuro Y., Uehara T., et al. Nuclear factor κB inactivation in the rat liver ameliorates short term total warm ischemia/reperfusion injury. Gut 54 (2005) 835
31. Kohli R., Harris D.C., and Whitington P.F. Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy. J Pediatr Gastroenterol Nutr 41 (2005) 121
32. Seal J.B., and Gewertz B.L. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 19 (2005) 1
33. Sud'ina G.F., Mirzoeva O.K., Pushkareva M.A., et al. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS 329 (1993) 21
34. Su M., Chi E.Y., Bishop M.J., et al. Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs. Am Rev Respir Dis 147 (1993) 448
35. Kanwar S., and Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol 267 (1994) G316
36. Patella V., Marino I., Arbustini E., et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97 (1998) 971
37. Lazarus B., Messina A., Barker J.E., et al. The role of mast cells in ischemia-reperfusion injury in murine skeletal muscle. J Pathol 191 (2000) 443
38. Bortolotto S.K., Morrison W.A., Han X., et al. Mast cells play a pivotal role in ischemia reperfusion injury to skeletal muscles. Lab Invest 84 (2004) 1103
39. Zhang F., Hu E.C., Gerzenshtein J., et al. The expression of proinflammatory cytokines in the rat muscle flap with ischemia-reperfusion injury. Ann Plast Surg 54 (2005) 313
40. Tsoulfas G., and Geller D.A. NF-κB in transplantation: Friend or foe?. Transpl Infect Dis 3 (2001) 212
41. Monici M.C., Aguennouz M., Mazzeo A., et al. Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 25 (2003) 993
42. Fan H., Sun B., Gu Q., et al. Oxygen radicals trigger activation of NF-κB and AP-1 and up-regulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 282 (2002) H1778
43. Maekawa N., Wada H., Kanda T., et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-α. J Am Coll Cardiol 39 (2002) 1229
44. Marquardt D.L., and Walker L.L. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity. J Allergy Clin Immunol 105 (2000) 500
45. Peng Y., Power M.R., Li B., et al. Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: A role for the IKK-IκB-NF-κB pathway in IgE-dependent mast cell activation. J Leukoc Biol 77 (2005) 975
46. Rushing G.D., and Britt L.D. Inhibition of NF-κB does not induce C-Jun N-terminal Kinase-mediated apoptosis in reperfusion injury. J Am Coll Surg 204 (2007) 964